Author:
Morgan B.,Lancaster R.,Boyagoda B.,Ananda R.,Attwood LO,Jacka D.,Woolley I.
Abstract
Abstract
Introduction
There are currently limited data regarding the clinical and economic significance of skin and soft tissue infections (SSTI) and bone and joint infections in Australian people who inject drugs (PWID).
Methods
Retrospective cohort study in adult PWID admitted to Monash Health, a large heath care network with six hospitals in Victoria, Australia. Inpatients were identified using administrative datasets and International Classification of Disease (ICD-10) coding for specific infection-related conditions. Cost analysis was based on mean ward, intensive care and hospital-in-the-home (HITH) lengths of stay. Spinal infections and endocarditis were excluded as part of previous studies.
Results
A total of 185 PWID (61 female, 124 male, median age 37) meeting the study criteria were admitted to Monash Health between January 2010 and January 2021. Admitting diagnoses included 78 skin abscesses, 80 cellulitis, 17 septic arthritis, 4 osteomyelitis, 3 thrombophlebitis and 1 each of necrotising fasciitis, vasculitis and myositis. Pain (87.5%) and swelling (75.1%) were the most common presenting complaints. Opioids (67.4%) and methamphetamine (37.5%) were the most common primary drugs injected. Almost half (46.5%) of patients had concurrent active hepatitis C (HCV) infection on admission. Hepatitis B (HBV) and Human Immunodeficiency Virus (HIV) were uncommon. The most significant causative organism was methicillin-susceptible Staphylococcus aureus (24.9%). In 40.0% (74/185) no organism was identified. Patients required a median acute hospital stay of 5 days (2–51 days). There were 15 patients admitted to the intensive care unit (ICU) with median duration 2 days. PICC line insertion for antibiotics was required in 16.8% of patients, while 51.4% required surgical intervention. Median duration of both oral and IV antibiotic therapy was 11 days. Almost half (48.6%) of patients were enrolled in an opioid maintenance program on discharge. Average estimated expenditure was AUD $16, 528 per admission.
Conclusion
Skin and soft tissue and joint infections are a major cause of morbidity for PWID. Admission to hospital provides opportunistic involvement of addiction specialty services.
Publisher
Springer Science and Business Media LLC
Reference32 articles.
1. Larney S, Hickman M, Guy R, Grebely J, Dore GJ, Gray RT, et al. Estimating the number of people who inject drugs in Australia. BMC Public Health. 2017;17(1):1–7.
2. Sutherland RU, King J, Jones C, Karlsson F, Gibbs A, Price D, Raimondo O, Dietze B, Lenton P, Salom S, Daly C, Thomas C, Juckel N, Agramunt J, Wilson S, Que Noy Y, Wilson W, Degenhardt J, Farrel L, Peacock M. A. Australian drug Trends 2022: key findings from the national illicit drug reporting system (IDRS) interviews. Australian Institute of Health and Welfare; 2022.
3. Nambiar D, Stoové M, Hickman M, Dietze P. A prospective cohort study of hospital separations among people who inject drugs in Australia: 2008–2013. BMJ open. 2017;7(8):e014854.
4. Chambers H. Skin and Soft Tissue Infections in persons who inject drugs. Infect Dis Clin N Am. 2021;35(1):169–81.
5. Collier MG, Doshani M, Asher A. Using Population based Hospitalization Data to Monitor increases in conditions causing morbidity among persons who inject drugs. J Community Health. 2018;43(3):598–603.